Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Mir

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
British Journal of Cancer|July 7, 2012
Sorafenib in advanced melanoma: a critical role for pharmacokinetics?N Pécuchet, C Lebbe, O Mir, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2011
Pregnancy-associated breast cancer is as chemosensitive as non-pregnancy-associated breast cancer in the neoadjuvant settingR Rouzier, G Werkoff, C Uzan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2011
Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE studyB Rousseau, P Loulergue, O Mir, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2019
Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumorC Henon, J-Y Blay, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2022
Investigation of sex and gender differences in oncology gains momentum: ESMO announces the launch of a Gender Medicine Task ForceB C Özdemir, S Oertelt-Prigione, A A Adjei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2011
Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trialJ P Durand, G Deplanque, V Montheil, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 19, 2014
Is preoperative radiotherapy suitable for all patients with primary soft tissue sarcoma of the limbs?A Levy, S Bonvalot, S Bellefqih, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 2014
Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patientsC Colombo, R Miceli, C Le Péchoux, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 20, 2023
Intraoperative motive for incomplete resection in primary retroperitoneal sarcomaB Acidi, M Faron, O Mir, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 19, 2019
Neoadjuvant isolated limb perfusion in newly diagnosed untreated patients with locally advanced soft tissue sarcomas of the extremities: the Gustave Roussy experienceT Assi, A Cavalcanti, A Le Cesne, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
British Journal of Cancer|July 7, 2012
Sorafenib in advanced melanoma: a critical role for pharmacokinetics?N Pécuchet, C Lebbe, O Mir, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2011
Pregnancy-associated breast cancer is as chemosensitive as non-pregnancy-associated breast cancer in the neoadjuvant settingR Rouzier, G Werkoff, C Uzan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2011
Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE studyB Rousseau, P Loulergue, O Mir, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 23, 2019
Long lasting major response to pembrolizumab in a thoracic malignant rhabdoid-like SMARCA4-deficient tumorC Henon, J-Y Blay, C Massard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2022
Investigation of sex and gender differences in oncology gains momentum: ESMO announces the launch of a Gender Medicine Task ForceB C Özdemir, S Oertelt-Prigione, A A Adjei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 24, 2011
Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trialJ P Durand, G Deplanque, V Montheil, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 19, 2014
Is preoperative radiotherapy suitable for all patients with primary soft tissue sarcoma of the limbs?A Levy, S Bonvalot, S Bellefqih, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 2014
Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patientsC Colombo, R Miceli, C Le Péchoux, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|October 20, 2023
Intraoperative motive for incomplete resection in primary retroperitoneal sarcomaB Acidi, M Faron, O Mir, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 19, 2019
Neoadjuvant isolated limb perfusion in newly diagnosed untreated patients with locally advanced soft tissue sarcomas of the extremities: the Gustave Roussy experienceT Assi, A Cavalcanti, A Le Cesne, et al.
Pageof 8